About the Wellcome Genome Campus
WGCL is the owner, operator and developer of the Wellcome Genome Campus, which is located nine miles south of Cambridge, within an established life science cluster and ecosystem. WGCL and the Campus are owned by a world-renowned endowment fund that is committed to expanding its existing campus into a global centre for genomics, biodata sciences and associated technologies.
By Tony Jones, CEO, One Nucleus - Email: [email protected]
BioInsight: Exploring Ideas, Enabling Impact
BioInsight is a new conference by Bionow which brings together the life sciences community of Scotland and beyond to share insights, technological and business developments and forge valuable new connections.
With a focus on translating and commercialising new technologies, BioInsight will explore the trends, technologies and collaborations shaping the future of the sector.
Applications are invited for an enthusiastic and motivated Research Associate to join the Laboratory of David Owen and Bernard Kelly at the Cambridge Institute for Medical Research. Our work combines cell biology, structural biology and biochemistry/biophysics to build a deep, integrated understanding of intracellular trafficking mechanisms, with a particular emphasis on cargo sorting in the endocytic system. The successful candidate will study the cell biology of receptor trafficking between the plasma membrane and endosomes.
Collaborating and Competing in the Brave New Biotech World
Tony Jones, CEO, One Nucleus, Email: [email protected]
Is it new, another cycle or evolution of the biotech sector?
Sandwich, UK — 10 June 2026: Discovery Park, Kent’s science and innovation hub, has launched the seventh edition of its Discovery Spark accelerator programme, welcoming 12 startups to its campus in Sandwich.
· Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1
· Comprehensive preclinical data package demonstrates differentiating oral activity and CNS penetration, unlocking treatment of primary and secondary brain cancers
· Dr Gabriel Fox appointed as Chief Medical Officer to lead clinical development
June 10, 2026 | 23:00 pm GMT+8
Chemical entities can be packed in different three-dimensional arrangements through various intermolecular interactions, resulting in multiple crystalline forms with distinct properties. In pharmaceutical development, these solid forms can directly influence drug performance and intellectual property strategy, making solid-state selection a critical consideration in early-stage development.
About us
The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff collaborate on vital research to help prevent, diagnose and treat illnesses such as cancer, heart disease, infectious diseases and neurodegenerative conditions.
The Innovation Summit is coming to Manchester in November. This free, one-day event is a great opportunity for cancer researchers to dive into the world of entrepreneurship. You'll join in-depth sessions with invaluable insights from industry leaders, network with fellow innovators and learn essential entrepreneurial skills in the heart of one of the UK's most exciting innovation ecosystems.